ZNF41 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.086800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.752000E-01
Normal-vs-Stage2
2.858600E-01
Normal-vs-Stage3
1.743000E-01
Normal-vs-Stage4
7.413200E-01
Stage1-vs-Stage2
3.924800E-01
Stage1-vs-Stage3
8.020100E-03
Stage1-vs-Stage4
3.847000E-01
Stage2-vs-Stage3
2.038700E-03
Stage2-vs-Stage4
4.845700E-02
Stage3-vs-Stage4
1.008830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.093200E-01
Normal-vs-AfricanAmerican
7.680000E-01
Normal-vs-Asian
1.486970E-01
Caucasian-vs-AfricanAmerican
3.942400E-01
Caucasian-vs-Asian
1.985190E-01
AfricanAmerican-vs-Asian
1.476970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.036800E-01
Normal-vs-Female
3.383200E-01
Male-vs-Female
8.259800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.140400E-01
Normal-vs-Age(41-60Yrs)
5.567200E-01
Normal-vs-Age(61-80Yrs)
2.591000E-01
Normal-vs-Age(81-100Yrs)
1.197190E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.482200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.654400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.479400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.223700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.436000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.118800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.186770E-01
Normal-vs-Daily Drinker
2.347000E-01
Normal-vs-Weekly Drinker
2.553200E-01
Normal-vs-Occasional Drinker
4.966600E-01
Normal-vs-Social Drinker
6.543000E-01
Non Drinker-vs-Daily Drinker
9.705000E-01
Non Drinker-vs-Weekly Drinker
7.626400E-01
Non Drinker-vs-Occasional Drinker
9.468300E-02
Non Drinker-vs-Social Drinker
6.998200E-02
Daily Drinker-vs-Weekly Drinker
8.316200E-01
Daily Drinker-vs-Occasional Drinker
1.899020E-01
Daily Drinker-vs-Social Drinker
1.522170E-01
Weekly Drinker-vs-Occasional Drinker
2.947200E-01
Weekly Drinker-vs-Social Drinker
2.390600E-01
Occasional Drinker-vs-Social Drinker
7.746000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.122240E-01
Normal-vs-Grade 2
4.861700E-02
Normal-vs-Grade 3
4.474400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.861000E-01
Grade 1-vs-Grade 3
4.805400E-01
Grade 1-vs-Grade 4
1.122240E-01
Grade 2-vs-Grade 3
2.324800E-01
Grade 2-vs-Grade 4
4.861700E-02
Grade 3-vs-Grade 4
4.474400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.055600E-01
Normal-vs-NonDiabetic
1.967370E-01
Diabetic-vs-NonDiabetic
8.488200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.198000E-02
Normal-vs-NoPancreatitis
2.305800E-01
Pancreatitis-vs-NoPancreatitis
2.055800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.092800E-01
Normal-vs-N1
3.277600E-01
N0-vs-N1
7.287800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.600200E-01
Normal-vs-TP53-NonMutant
6.656600E-01
TP53-Mutant-vs-TP53-NonMutant
9.226200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
